{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:50:51Z","timestamp":1761540651121,"version":"build-2065373602"},"reference-count":105,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":6342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1111\/j.1538-7836.2005.01417.x","type":"journal-article","created":{"date-parts":[[2005,8,8]],"date-time":"2005-08-08T04:34:38Z","timestamp":1123475678000},"page":"1603-1610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Thrombophilia and pregnancy outcomes"],"prefix":"10.1016","volume":"3","author":[{"given":"I.","family":"PABINGER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"VORMITTAG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/107602960000600301","article-title":"Recurrent miscarriage syndrome due to blood coagulation protein\/platelet defects: prevalence, treatment and outcome results. DRW Metroplex Recurrent Miscarriage Syndrome Cooperative Group","volume":"6","author":"Bick","year":"2000","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jama.1997.03540290035029","article-title":"Major depressive disorder in the 6\u2003months after miscarriage","volume":"277","author":"Neugebauer","year":"1997","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0020","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4088\/JCP.v62n0606","article-title":"Anxiety disorders following miscarriage","volume":"62","author":"Geller","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/01674829609025678","article-title":"Pregnancy following miscarriage: course of grief and some determining factors","volume":"17","author":"Cuisinier","year":"1996","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0030","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1055\/s-0037-1615035","article-title":"Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy","volume":"79","author":"Clark","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0035","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-0038-1661167","article-title":"Haemostasis in normal pregnancy","volume":"52","author":"Stirling","year":"1984","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0040","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood.V68.4.881.881","article-title":"Functional and immunologic protein S levels are decreased during pregnancy","volume":"68","author":"Comp","year":"1986","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0045","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/bmj.3.5667.387","article-title":"Fibrinolytic enzyme system and pregnancy","volume":"3","author":"Bonnar","year":"1969","journal-title":"Br Med J"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0028-2243(82)90028-4","article-title":"The coagulation and fibrinolytic enzyme system in pregnancy and in the puerperium","volume":"13","author":"Beller","year":"1982","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0055","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","article-title":"Low\u2010molecular\u2010weight heparin versus low\u2010dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder","volume":"103","author":"Gris","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0060","first-page":"1","article-title":"Abortion","volume":"1","author":"Sondheimer","year":"1999","journal-title":"Encyclopedia Reprod"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1521-6926(02)00094-4","article-title":"Antiphospholipid antibodies and pregnancy","volume":"16","author":"Galli","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0070","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0015-0282(16)56282-7","article-title":"Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss","volume":"60","author":"Wouters","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0075","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(96)04125-6","article-title":"Increased fetal loss in women with heritable thrombophilia","volume":"348","author":"Preston","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0080","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1365-2141.0000.d01-1465.x","article-title":"Second\u2010trimester pregnancy loss is associated with activated C resistance","volume":"92","author":"Rai","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0085","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0038-1650282","article-title":"The risk of abortion and stillbirth in antithrombin\u2010, protein C\u2010, and protein S\u2010deficient women","volume":"75","author":"Sanson","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM199901073400102","article-title":"Increased frequency of genetic thrombophilia in women with complications of pregnancy","volume":"340","author":"Kupferminc","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0095","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1055\/s-0038-1656119","article-title":"Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study","volume":"77","author":"Gris","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0100","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1055\/s-0038-1656060","article-title":"Factor V Leiden is associated with repeated and recurrent unexplained fetal losses","volume":"77","author":"Grandone","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0105","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJM200010053431405","article-title":"Mutations in coagulation factors in women with unexplained late fetal loss","volume":"343","author":"Martinelli","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.8755-8920.2000.430106.x","article-title":"Activated protein C resistance and factor V Leiden mutation can be associated with first\u2010 as well as second\u2010trimester recurrent pregnancy loss","volume":"43","author":"Younis","year":"2000","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0115","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.8755-8920.2001.460202.x","article-title":"Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester","volume":"46","author":"Pihusch","year":"2001","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0120","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1067\/mob.2002.126849","article-title":"Acquired and inherited thrombophilia in women with unexplained fetal losses","volume":"187","author":"Alonso","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0125","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.0001-6349.2004.00566.x","article-title":"High frequency of congenital thrombophilia in women with pathological pregnancies","volume":"83","author":"Rasmussen","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0130","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-0037-1614001","article-title":"Antiphospholipid and antiprotein syndromes in non\u2010thrombotic, non\u2010autoimmune women with unexplained recurrent primary early foetal loss. The Nimes Obstetricians and Haematologists Study \u2013 NOHA","volume":"84","author":"Gris","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0135","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/humrep\/16.5.961","article-title":"Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage","volume":"16","author":"Rai","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0140","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/humrep\/17.6.1633","article-title":"Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss","volume":"17","author":"Carp","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0145","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1160\/TH03-10-0637","article-title":"The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta\u2010analysis","volume":"91","author":"Dudding","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0150","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/archinte.164.5.558","article-title":"Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta\u2010analysis","volume":"164","author":"Kovalevsky","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0155","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(03)12771-7","article-title":"Thrombophilic disorders and fetal loss: a meta\u2010analysis","volume":"361","author":"Rey","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0160","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/humrep\/14.7.1872","article-title":"The factor V Leiden mutation in Japanese couples with recurrent spontaneous abortion","volume":"14","author":"Hashimoto","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0165","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1055\/s-0037-1614519","article-title":"Activated protein C resistance (FV: Q506) and pregnancy","volume":"81","author":"Lindqvist","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0170","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/01.ATV.20.1.266","article-title":"Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy","volume":"20","author":"Murphy","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0175","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1538-7836.2003.00066.x","article-title":"Thromboprophylaxis improves the live birth rate in women with consecutive recurrent miscarriages and hereditary thrombophilia","volume":"1","author":"Carp","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0180","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/10641950109152640","article-title":"Low\u2010molecular\u2010weight heparin for the prevention of obstetric complications in women with thrombophilias","volume":"20","author":"Kupferminc","year":"2001","journal-title":"Hypertens Pregnancy"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0185","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low\u2010molecular\u2010weight heparin in pregnancy: a systematic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0190","first-page":"267","article-title":"Thromboprophylaxis throughout pregnancy in women with previous history of recurrent miscarriages of unknown aetiology","volume":"29","author":"Tzafettas","year":"2002","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0195","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0037-1613894","article-title":"Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin","volume":"83","author":"Brenner","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0200","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00006250-200212000-00032","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0205","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/oxfordjournals.humrep.a138137","article-title":"A prospective study of 63 couples with a history of recurrent spontaneous abortion: contributing factors and outcome of subsequent pregnancies","volume":"8","author":"Tulppala","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0210","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/00016348509155129","article-title":"The course of pregnancy following spontaneous abortion","volume":"64","author":"Rud","year":"1985","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0215","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/bmj.299.6698.541","article-title":"Influence of past reproductive performance on risk of spontaneous abortion","volume":"299","author":"Regan","year":"1989","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0220","series-title":"Encyclopedia of Reproduction","first-page":"964","article-title":"Pre\u2010eclampsia\/eclampsia","author":"Magann","year":"1998"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0225","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0002-9378(90)91176-D","article-title":"Epidemiology of preeclampsia and eclampsia in the United States, 1979\u20131986","volume":"163","author":"Saftlas","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0230","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(00)03577-7","article-title":"Pathogenesis and genetics of pre\u2010eclampsia","volume":"357","author":"Roberts","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0235","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case\u2010control study. World Health Organization Collaborative Study of cardiovascular disease and steroid hormone contraception","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0240","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/bmj.326.7393.791","article-title":"Risk of subsequent thromboembolism for patients with pre\u2010eclampsia","volume":"326","author":"van Walraven","year":"2003","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0245","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1046\/j.1365-2141.1996.410947.x","article-title":"HELLP syndrome associated with factor V R506Q mutation","volume":"92","author":"Brenner","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0250","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-9378(96)80022-6","article-title":"The factor V Leiden mutation may predispose women to severe preeclampsia","volume":"175","author":"Dizon\u2010Townson","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0255","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9378(97)70515-5","article-title":"Preeclampsia is associated with a reduced response to activated protein C","volume":"176","author":"Lindoff","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0260","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1055\/s-2007-994955","article-title":"The factor V Leiden mutation is not a common cause of pregnancy\u2010induced hypertension in Japan","volume":"25","author":"Kobashi","year":"1999","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0265","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0002-9378(99)70335-2","article-title":"Preeclampsia and genetic risk factors for thrombosis: a case\u2010control study","volume":"181","author":"De Groot","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0270","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0037-1614475","article-title":"Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria","volume":"81","author":"Grandone","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0275","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1093\/humrep\/14.12.3112","article-title":"Activated protein C resistance shows an association with pregnancy\u2010induced hypertension","volume":"14","author":"Horstkamp","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0280","first-page":"197","article-title":"Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies","volume":"29","author":"Mello","year":"1999","journal-title":"Haemostasis"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0285","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/01.HYP.33.6.1338","article-title":"Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort","volume":"33","author":"O'Shaughnessy","year":"1999","journal-title":"Hypertension"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0290","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0002-9378(99)70608-3","article-title":"High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia","volume":"180","author":"van Pampus","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0295","first-page":"45","article-title":"Severe preeclampsia and high frequency of genetic thrombophilic mutations","volume":"96","author":"Kupferminc","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0300","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1081\/PRG-100100132","article-title":"Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase","volume":"19","author":"Rigo","year":"2000","journal-title":"Hypertens Pregnancy"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0305","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0049-3848(00)00312-1","article-title":"Incidence of the factor V Leiden\u2010mutation, coagulation inhibitor deficiency, and elevated antiphospholipid\u2010antibodies in patients with preeclampsia or HELLP\u2010syndrome. Hemolysis, elevated liver\u2010enzymes, low platelets","volume":"100","author":"von Tempelhoff","year":"2000","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0310","first-page":"44","article-title":"Genetic hypofibrinolysis in complicated pregnancies","volume":"97","author":"Glueck","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0315","first-page":"753","article-title":"Postnatal screening for thrombophilia in women with severe pregnancy complications","volume":"97","author":"Alfirevic","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0320","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1067\/mob.2001.110411","volume":"184","author":"Kim","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0325","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1067\/mob.2001.114691","article-title":"Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia","volume":"185","author":"Livingston","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0330","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1479-828X.1998.tb03002.x","article-title":"Changes of resistance to activated protein C in the course of pregnancy and prevalence of factor V mutation","volume":"38","author":"Mimuro","year":"1998","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0335","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/00004872-200307000-00002","article-title":"Association of Leiden mutation in factor V gene with hypertension in pregnancy and pre\u2010eclampsia: a meta\u2010analysis","volume":"21","author":"Kosmas","year":"2003","journal-title":"J Hypertens"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0340","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/00004872-200409000-00004","article-title":"Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre\u2010eclampsia: a meta\u2010analysis","volume":"22","author":"Kosmas","year":"2004","journal-title":"J Hypertens"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0345","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1055\/s-0037-1613083","article-title":"Prothrombotic genotypes are not associated with pre\u2010eclampsia and gestational hypertension: results from a large population\u2010based study and systematic review","volume":"87","author":"Morrison","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0350","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/j.1538-7836.2004.00861.x","article-title":"Preeclampsia and its interaction with common variants in thrombophilia genes","volume":"2","author":"De Maat","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0355","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.0001-6349.2004.00291.x","article-title":"Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction","volume":"83","author":"D'Anna","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0360","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low\u2010dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal\u2010Fetal Medicine Units","volume":"338","author":"Caritis","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0365","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low\u2010dose aspirin for the prevention and treatment of pre\u2010eclampsia among 9364 pregnant women. CLASP (Collaborative Low\u2010dose Aspirin Study in Pregnancy) Collaborative Group","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0370","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1034\/j.1600-0412.2000.079011963.x","article-title":"High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss","volume":"79","author":"Kupferminc","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0375","first-page":"428","article-title":"Familial thrombophilia and the occurrence of fetal growth restriction","volume":"86","author":"Martinelli","year":"2001","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0380","first-page":"1373","article-title":"Mid\u2010trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia","volume":"109","author":"Kupferminc","year":"2002","journal-title":"BJOG"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0385","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199110103251503","article-title":"Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case\u2010control study","volume":"325","author":"Infante\u2010Rivard","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0390","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/ajcn\/71.4.962","article-title":"Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine Study","volume":"71","author":"Vollset","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0395","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(05)74935-7","article-title":"Acquired activated protein\u2010C resistance in pregnancy and association with increased thrombin generation and fetal weight","volume":"353","author":"Clark","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0400","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9378(98)70263-7","article-title":"Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction","volume":"179","author":"Leeda","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0405","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.ATV.21.5.874","article-title":"Preeclampsia and fetal loss in women with a history of venous thromboembolism","volume":"21","author":"Pabinger","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0410","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2002-01-0149","article-title":"Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism","volume":"100","author":"Pabinger","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0415","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-0038-1645218","article-title":"Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women","volume":"63","author":"Conard","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0420","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/01.ATV.16.6.742","article-title":"Thrombotic risk in hereditary antithrombin III, protein C, or protein S deficiency. A cooperative, retrospective study. Gesellschaft fur Thrombose\u2010 und Hamostaseforschung (GTH) Study Group on natural inhibitors","volume":"16","author":"Pabinger","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0425","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0002-9378(89)90095-1","article-title":"Recurrent thromboembolism in pregnancy and puerperium. Is there a need for thromboprophylaxis","volume":"160","author":"Tengborn","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0430","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.thj.6200005","article-title":"Pregnancy\u2010associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden","volume":"1","author":"Pabinger","year":"2000","journal-title":"Hematol J"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0435","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1056\/NEJM200011163432002","article-title":"Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of clot in this Pregnancy Study Group","volume":"343","author":"Brill\u2010Edwards","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0440","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1538-7836.2005.01307.x","article-title":"Risk of pregnancy\u2010associated recurrent venous thromboembolism in women with a history of venous thrombosis","volume":"3","author":"Pabinger","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0445","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJM198511213132104","article-title":"Obstetric complications associated with the lupus anticoagulant","volume":"313","author":"Branch","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0450","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1600-0897.1989.tb01016.x","article-title":"Antiphospholipid antibodies and reproduction","volume":"21","author":"Triplett","year":"1989","journal-title":"Am J Reprod Immunol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0455","doi-asserted-by":"crossref","first-page":"736","DOI":"10.7326\/0003-4819-130-9-199905040-00013","article-title":"Increased risk for fetal loss in carriers of the factor V Leiden mutation","volume":"130","author":"Meinardi","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0460","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1055\/s-0037-1614367","article-title":"The risk of fetal loss in family members of probands with factor V Leiden mutation","volume":"82","author":"Tormene","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0465","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1538-7836.2004.00662.x","article-title":"Hereditary thrombophilia and fetal loss: a prospective follow\u2010up study","volume":"2","author":"Vossen","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0470","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1093\/oxfordjournals.humrep.a135907","article-title":"High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies","volume":"10","author":"Rai","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0475","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(05)60080-3","article-title":"Action of anticardiolipin and antibodies to beta2\u2010glycoprotein\u2010I on trophoblast proliferation as a mechanism for fetal death","volume":"352","author":"Chamley","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0480","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0485","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody\u2010associated recurrent pregnancy loss: treatment with heparin and low\u2010dose aspirin is superior to low\u2010dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0490","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1067\/mob.2000.106754","article-title":"Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial","volume":"183","author":"Pattison","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0495","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","article-title":"Mutation in blood coagulation factor V associated with resistance to activated protein C","volume":"369","author":"Bertina","year":"1994","journal-title":"Nature"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0500","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM199603213341203","article-title":"Hyperhomocysteinemia as a risk factor for deep\u2010vein thrombosis","volume":"334","author":"den Heijer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0505","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1056\/NEJM199011293232202","article-title":"Deficiencies of coagulation\u2010inhibiting and fibrinolytic proteins in outpatients with deep\u2010vein thrombosis","volume":"323","author":"Heijboer","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0510","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(05)80081-9","article-title":"Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study","volume":"342","author":"Koster","year":"1993","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0515","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJM198710153171604","article-title":"Absence of thrombosis in subjects with heterozygous protein C deficiency","volume":"317","author":"Miletich","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0520","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00001721-199210000-00005","article-title":"Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening","volume":"3","author":"Pabinger","year":"1992","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0525","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2141.1994.tb04878.x","article-title":"Prevalence of antithrombin deficiency in the healthy population","volume":"87","author":"Tait","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01417.x_bb0530","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0038-1653730","article-title":"Prevalence of protein C deficiency in the healthy population","volume":"73","author":"Tait","year":"1995","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2005.01417.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622163142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622163142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2005.01417.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:36:14Z","timestamp":1761532574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622163142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":105,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S1538783622163142"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01417.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombophilia and pregnancy outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01417.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}